China Health Group (FRA:VNL1) EV-to-EBITDA : -1.73 (As of Sep. 25, 2024)

China Health Group EV-to-EBITDA Chart

China Health Group Annual Data
	Trend	Dec12	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBITDA		Get a 7-Day Free Trial					2.50	4.45	6.92	-15.71	-2.03

China Health Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
EV-to-EBITDA	Get a 7-Day Free Trial															-59.11	-17.09	-14.19	-2.03	-

Competitive Comparison of China Health Group's EV-to-EBITDA

For the Diagnostics & Research subindustry, China Health Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Group's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where China Health Group's EV-to-EBITDA falls into.

China Health Group EV-to-EBITDA Calculation

China Health Group's EV-to-EBITDA for today is calculated as:

China Health Group's current Enterprise Value is €12.87 Mil.
China Health Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Group  (FRA:VNL1) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

China Health Group's PE Ratio for today is calculated as:

China Health Group's share price for today is €0.004.
China Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.007.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

China Health Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of China Health Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Group Business Description